Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19

Review (12 RCTs; n= 8569) found hydroxychloroquine has minimal effect on risk of mortality, no effect on progression to mechanical ventilation, and is associated with triple the number of adverse events vs placebo, therefore no further treatment trials should be carried out.

Source:

Cochrane Database of Systematic Reviews